Company / Income Tax per Share
Monte Rosa Therapeutics, Inc. Income Tax per Share History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
$0.03
FY2024
5-year range
$0.00 / $0.03
FY2022-FY2024
Trend
+428.8%
vs FY2023
Sector context
#59 of 201
Health Care
What the data says
At $0.03, Monte Rosa Therapeutics, Inc.'s income tax per share ranks #143 of 201 in the Health Care sector. Increased from $0.00 to $0.03 over the past 2 years.
Based on SEC 10-K filings.
0.03 in FY2024.
Increased from $0.00 to $0.03 over the past 2 years.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#143 of 201 in Health CareTop 71% of 201This company $0.03 Sector average $1.35
▼
-97.4% below sector average
Key checks
Key Insights
- In FY2024, income tax per share increased 428.8% year-over-year.
- Ranks #59 out of 201 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.03 | +428.8% |
| FY2023 | $0.01 | - |
| FY2022 | $0.00 | - |
| FY2021 | - | - |
| FY2020 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026